7-(5-fluoro-2,3-dihydroindol-1-yl)-N-(oxolan-3-ylmethyl)-[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide
C19H18FN5O2S — CID 135390006
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-(5-fluoro-2,3-dihydroindol-1-yl)-N-(oxolan-3-ylmethyl)-[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide
7-(5-fluoro-2,3-dihydroindol-1-yl)-N-(oxolan-3-ylmethyl)-[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide (PubChem CID 135390006) has the molecular formula C19H18FN5O2S and a molecular weight of 399.45 g/mol. Its IUPAC name is 7-(5-fluoro-2,3-dihydroindol-1-yl)-N-(oxolan-3-ylmethyl)-[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide.
Molecular Properties
| Compound Name | 7-(5-fluoro-2,3-dihydroindol-1-yl)-N-(oxolan-3-ylmethyl)-[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide |
|---|---|
| PubChem CID | 135390006 |
| Molecular Formula | C19H18FN5O2S |
| Molecular Weight | 399.45 g/mol |
| Exact Mass | 399.12 |
| IUPAC Name | 7-(5-fluoro-2,3-dihydroindol-1-yl)-N-(oxolan-3-ylmethyl)-[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide |
| SMILES | O=C(NCC1CCOC1)c1nc2c(N3CCc4cc(F)ccc43)ncnc2s1 |
| InChI | InChI=1S/C19H18FN5O2S/c20-13-1-2-14-12(7-13)3-5-25(14)16-15-18(23-10-22-16)28-19(24-15)17(26)21-8-11-4-6-27-9-11/h1-2,7,10-11H,3-6,8-9H2,(H,21,26) |
| InChIKey | YARUDKDWMFHNKE-UHFFFAOYSA-N |
| XLogP | 2.69 |
| TPSA | 80.24 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 399.45 |
| LogP ≤ 5 | 2.69 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135390006 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.